Dokument
| Titel: | The rationale for the treatment of long-Covid symptoms – A cardiologist's view |
| Autor: | Schieffer, Elisabeth |
| Weitere Verfasser: | Schieffer, Bernhard |
| Veröffentlicht: | 2022 |
| URI: | https://archiv.ub.uni-marburg.de/es/2023/0057 |
| DOI: | https://doi.org/10.3389/fcvm.2022.992686 |
| URN: | urn:nbn:de:hebis:04-es2023-00570 |
| DDC: | 610 Medizin |
| Publikationsdatum: | 2023-05-16 |
| Lizenz: | https://creativecommons.org/licenses/by/4.0 |
| Schlagwörter: |
|---|
| lipid – hybrid nanoparticles, renin-angiotensin system, kalkrein-kinin system, histamin challenge, HDL - cholesterol, long-Covid syndrome, cholesterol |
Summary:
The ongoing coronavirus disease 2019 pandemic left us with thousands of patients suffering from neurological, cardiovascular, and psychiatric disorders named post-acute sequelae of COVID-19 or just long-Covid. In parallel, the vaccination campaigns against SARS-CoV-2 spike protein saved millions of lives worldwide but long-Covid symptoms also appeared rarely following vaccination with a strong overlap to the “canonical” long-Covid symptoms. A therapeutic strategy targeting both, post-VAC and post-SARS-CoV-2 long-Covid symptoms is warranted since exposure to the S-protein either by vaccination or SARS-CoV-2 infection may trigger identical immuno-inflammatory cascades resulting in long-Covid symptoms.
 | Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten |